NCT01432392View on ClinicalTrials.gov

Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease

CompletedOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Gastroesophageal Reflux Disease

Trial Locations (2)

Unknown

Sofia

Varna

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY